Elion Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- June 17, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $81,000,000
Company Info
- Founders
- Kieren Marr
- Company Description
- Elion Therapeutics is a cutting-edge biotechnology business focused on treating life-threatening IFIs
- Market
- Life-threatening Invasive Fungal Infections (IFIs)
- Location
- New York, New York, USA
- Coinvestors
- BAMR Action Fund, Deerfield Management Company, L.P., Illinois Ventures